Fredericton, New Brunswick, Jan. 10, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) ( FSE:Z12) (“ NextGen ” or the “ Company ”) announces that it will proceed with a non-brokered ...

Mr. Brabazon’s professional qualifications include a Bachelor of Commerce from the University of Auckland, a Chartered Fellow of the Institute of Directors in New Zealand, and a Fellow of the ...

Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused drug development company, today ...

The Company acquired 1.13% of the Equity Share Capital of M/s. India Infoline Finance Limited ... 2020 due to sale of Clara Developers Private Limited. As of March 31, 2021, AUM stood at Rs ...

Sammaan Capital Ltd share price was down by -5.44% from the previous closing price of ₹149.71. Who are peers of Sammaan Capital Ltd? The peers of Sammaan Capital Ltd are Bajaj Finance Ltd ...

Partners from Latham, Proskauer, Kirkland, Morrison Foerster and Skadden say they are optimistic about 2025, citing activity ...

The main industry in which Dam Capital Advisors Ltd operates is Finance & Investments ... Capital Advisors Ltd. Collaboration between ISRO, private companies and start-ups will drive India ...

Greaves Electric Mobility Limited (GEML), the e-mobility division of Greaves Cotton Limited, has introduced Ampere Magnus Neo, an enhanced variant of its Magnus electric scooter that promises 'The ...

Lithium South Development Corporation (the "Company" or "Lithium South") is pleased to announce the signing of a Letter of Intent ("LOI")( January 10, 2025 )for the cooperative development of the ...

Earn 5 miles per dollar on hotels and rental cars booked through Capital One Travel. Earn unlimited 1.25X miles on every purchase. $0 0% intro APR on purchases and balance transfers for 15 months ...

Earn 5x miles per dollar on hotels, vacation rentals, and rental cars booked through Capital One Travel. Earn unlimited 2x miles on every purchase. $95 N/A 19.99% - 29.24% variable Earn 75,000 ...

Inhibrx Biosciences, Inc. ("Inhibrx" or the "Company") (Nasdaq: INBX), a biopharmaceutical company with two programs in ongoing clinical trials, today announced it entered into a loan and security ...